Redox Biology (May 2020)

Molecular pathways driving omeprazole nephrotoxicity

  • Miguel Fontecha-Barriuso,
  • Diego Martín-Sanchez,
  • Julio M. Martinez-Moreno,
  • Daniela Cardenas-Villacres,
  • Susana Carrasco,
  • Maria D. Sanchez-Niño,
  • Marta Ruiz-Ortega,
  • Alberto Ortiz,
  • Ana B. Sanz

Journal volume & issue
Vol. 32

Abstract

Read online

Omeprazole, a proton pump inhibitor used to treat peptic ulcer and gastroesophageal reflux disease, has been associated to chronic kidney disease and acute interstitial nephritis. However, whether omeprazole is toxic to renal cells is unknown. Omeprazole has a lethal effect over some cancer cells, and cell death is a key process in kidney disease. Thus, we evaluated the potential lethal effect of omeprazole over tubular cells.Omeprazole induced dose-dependent cell death in human and murine proximal tubular cell lines and in human primary proximal tubular cell cultures. Increased cell death was observed at the high concentrations used in cancer cell studies and also at lower concentrations similar to those in peptic ulcer patient serum. Cell death induced by omeprazole had features of necrosis such as annexin V/7-AAD staining, LDH release, vacuolization and irregular chromatin condensation. Weak activation of caspase-3 was observed but inhibitors of caspases (zVAD), necroptosis (Necrostatin-1) or ferroptosis (Ferrostatin-1) did not prevent omeprazole-induced death. However, omeprazole promoted a strong oxidative stress response affecting mitochondria and lysosomes and the antioxidant N-acetyl-cysteine reduced oxidative stress and cell death. By contrast, iron overload increased cell death. An adaptive increase in the antiapoptotic protein BclxL failed to protect cells. In mice, parenteral omeprazole increased tubular cell death and the expression of NGAL and HO-1, markers of renal injury and oxidative stress, respectively.In conclusion, omeprazole nephrotoxicity may be related to induction of oxidative stress and renal tubular cell death.

Keywords